Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Systems serology for evaluation of HIV vaccine trials
Margaret E. Ackerman, Dan H. Barouch, Galit Alter
Immunological Reviews (2017) Vol. 275, Iss. 1, pp. 262-270
Open Access | Times Cited: 70

Showing 1-25 of 70 citing articles:

Machine learning for clinical decision support in infectious diseases: a narrative review of current applications
Nathan Peiffer‐Smadja, Timothy M. Rawson, Raheelah Ahmad, et al.
Clinical Microbiology and Infection (2019) Vol. 26, Iss. 5, pp. 584-595
Open Access | Times Cited: 373
Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease
Elisabeth A. van Erp, Willem Luytjes, Gerben Ferwerda, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 238
A versatile high-throughput assay to characterize antibody-mediated neutrophil phagocytosis
Christina B. Karsten, Nickita Mehta, Sally Shin, et al.
Journal of Immunological Methods (2019) Vol. 471, pp. 46-56
Open Access | Times Cited: 149
Fc-γR-dependent antibody effector functions are required for vaccine-mediated protection against antigen-shifted variants of SARS-CoV-2
Samantha Mackin, Pritesh Desai, Bradley Whitener, et al.
Nature Microbiology (2023) Vol. 8, Iss. 4, pp. 569-580
Open Access | Times Cited: 83
Antibody-mediated protection against Ebola virus
Erica Ollmann Saphire, Sharon L. Schendel, Bronwyn M. Gunn, et al.
Nature Immunology (2018) Vol. 19, Iss. 11, pp. 1169-1178
Open Access | Times Cited: 140
The quest for an antibody-based HIV vaccine
Barton F. Haynes, John R. Mascola
Immunological Reviews (2017) Vol. 275, Iss. 1, pp. 5-10
Open Access | Times Cited: 95
Antibodies and tuberculosis: finally coming of age?
Hao Li, Babak Javid
Nature reviews. Immunology (2018) Vol. 18, Iss. 9, pp. 591-596
Open Access | Times Cited: 88
Innate transcriptional effects by adjuvants on the magnitude, quality, and durability of HIV envelope responses in NHPs
Joseph R. Francica, Daniel E. Zak, Caitlyn Linde, et al.
Blood Advances (2017) Vol. 1, Iss. 25, pp. 2329-2342
Open Access | Times Cited: 84
Prospects from systems serology research
Kelly B. Arnold, Amy W. Chung
Immunology (2017) Vol. 153, Iss. 3, pp. 279-289
Open Access | Times Cited: 74
Systems vaccinology and big data in the vaccine development chain
René H. M. Raeven, Elly van Riet, Hugo D. Meiring, et al.
Immunology (2018) Vol. 156, Iss. 1, pp. 33-46
Open Access | Times Cited: 74
Broadly neutralizing antibodies for HIV-1: efficacies, challenges and opportunities
Yubin Liu, Wei Cao, Ming Sun, et al.
Emerging Microbes & Infections (2020) Vol. 9, Iss. 1, pp. 194-206
Open Access | Times Cited: 68
Advances in HIV-1 Vaccine Development
Yong Gao, Paul F. McKay, Jamie F. S. Mann
Viruses (2018) Vol. 10, Iss. 4, pp. 167-167
Open Access | Times Cited: 61
Co-immunization of DNA and Protein in the Same Anatomical Sites Induces Superior Protective Immune Responses against SHIV Challenge
Barbara K. Felber, Zhongyan Lu, Xintao Hu, et al.
Cell Reports (2020) Vol. 31, Iss. 6, pp. 107624-107624
Open Access | Times Cited: 52
Enhancing Immunity with Nanomedicine: Employing Nanoparticles to Harness the Immune System
Cátia T. Perciani, Lewis Liu, Laurence M. Wood, et al.
ACS Nano (2020) Vol. 15, Iss. 1, pp. 7-20
Closed Access | Times Cited: 49
Knowns and Unknowns of Assaying Antibody-Dependent Cell-Mediated Cytotoxicity Against HIV-1
George K. Lewis, Margaret E. Ackerman, Gabriella Scarlatti, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 45
Predictive Markers of Immunogenicity and Efficacy for Human Vaccines
Matthieu Van Tilbeurgh, Katia Lemdani, Anne‐Sophie Beignon, et al.
Vaccines (2021) Vol. 9, Iss. 6, pp. 579-579
Open Access | Times Cited: 38
The Status and Prospects of Epstein–Barr Virus Prophylactic Vaccine Development
Cong Sun, Xinchun Chen, Yinfeng Kang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 33
High‐resolution definition of humoral immune response correlates of effective immunity against HIV
Galit Alter, Karen G. Dowell, Eric P. Brown, et al.
Molecular Systems Biology (2018) Vol. 14, Iss. 3
Open Access | Times Cited: 43
A Systems Vaccinology Approach Reveals Temporal Transcriptomic Changes of Immune Responses to the Yellow Fever 17D Vaccine
Jue Hou, Shuhui Wang, Manxue Jia, et al.
The Journal of Immunology (2017) Vol. 199, Iss. 4, pp. 1476-1489
Open Access | Times Cited: 42
Passive and active antibody studies in primates to inform HIV vaccines
Ann J. Hessell, Delphine C. Malherbe, Nancy L. Haigwood
Expert Review of Vaccines (2018), pp. 1-18
Open Access | Times Cited: 39
Autoantigenomics: Holistic characterization of autoantigen repertoires for a better understanding of autoimmune diseases
Christian P. Moritz, Stéphane Paul, Oda Stoevesandt, et al.
Autoimmunity Reviews (2019) Vol. 19, Iss. 2, pp. 102450-102450
Open Access | Times Cited: 38
Multimeric Epitope-Scaffold HIV Vaccines Target V1V2 and Differentially Tune Polyfunctional Antibody Responses
Ann J. Hessell, Rebecca Powell, Xunqing Jiang, et al.
Cell Reports (2019) Vol. 28, Iss. 4, pp. 877-895.e6
Open Access | Times Cited: 37
Persistence of viral RNA in lymph nodes in ART-suppressed SIV/SHIV-infected Rhesus Macaques
Anthony M. Cadena, John D. Ventura, Peter Abbink, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 29
Bacille Calmette-Guérin vaccine reprograms human neonatal lipid metabolism in vivo and in vitro
Joann Diray‐Arce, Asimenia Angelidou, Kristoffer Jarlov Jensen, et al.
Cell Reports (2022) Vol. 39, Iss. 5, pp. 110772-110772
Open Access | Times Cited: 21
Afucosylation of HLA-specific IgG1 as a potential predictor of antibody pathogenicity in kidney transplantation
Pranay Bharadwaj, Sweta Shrestha, Tamás Pongrácz, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 11, pp. 100818-100818
Open Access | Times Cited: 21
Page 1 - Next Page

Scroll to top